Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Do critical illness survivors with multimorbidity need a different model of care?

View through CrossRef
AbstractThere is currently a lack of evidence on the optimal strategy to support patient recovery after critical illness. Previous research has largely focussed on rehabilitation interventions which aimed to address physical, psychological, and cognitive functional sequelae, the majority of which have failed to demonstrate benefit for the selected outcomes in clinical trials. It is increasingly recognised that a person’s existing health status, and in particular multimorbidity (usually defined as two or more medical conditions) and frailty, are strongly associated with their long-term outcomes after critical illness. Recent evidence indicates the existence of a distinct subgroup of critical illness survivors with multimorbidity and high healthcare utilisation, whose prior health trajectory is a better predictor of long-term outcomes than the severity of their acute illness. This review examines the complex relationships between multimorbidity and patient outcomes after critical illness, which are likely mediated by a range of factors including the number, severity, and modifiability of a person’s medical conditions, as well as related factors including treatment burden, functional status, healthcare delivery, and social support. We explore potential strategies to optimise patient recovery after critical illness in the presence of multimorbidity. A comprehensive and individualized approach is likely necessary including close coordination among healthcare providers, medication reconciliation and management, and addressing the physical, psychological, and social aspects of recovery. Providing patient-centred care that proactively identifies critical illness survivors with multimorbidity and accounts for their unique challenges and needs is likely crucial to facilitate recovery and improve outcomes.
Title: Do critical illness survivors with multimorbidity need a different model of care?
Description:
AbstractThere is currently a lack of evidence on the optimal strategy to support patient recovery after critical illness.
Previous research has largely focussed on rehabilitation interventions which aimed to address physical, psychological, and cognitive functional sequelae, the majority of which have failed to demonstrate benefit for the selected outcomes in clinical trials.
It is increasingly recognised that a person’s existing health status, and in particular multimorbidity (usually defined as two or more medical conditions) and frailty, are strongly associated with their long-term outcomes after critical illness.
Recent evidence indicates the existence of a distinct subgroup of critical illness survivors with multimorbidity and high healthcare utilisation, whose prior health trajectory is a better predictor of long-term outcomes than the severity of their acute illness.
This review examines the complex relationships between multimorbidity and patient outcomes after critical illness, which are likely mediated by a range of factors including the number, severity, and modifiability of a person’s medical conditions, as well as related factors including treatment burden, functional status, healthcare delivery, and social support.
We explore potential strategies to optimise patient recovery after critical illness in the presence of multimorbidity.
A comprehensive and individualized approach is likely necessary including close coordination among healthcare providers, medication reconciliation and management, and addressing the physical, psychological, and social aspects of recovery.
Providing patient-centred care that proactively identifies critical illness survivors with multimorbidity and accounts for their unique challenges and needs is likely crucial to facilitate recovery and improve outcomes.

Related Results

Multimorbidity and blood pressure control: a cross-sectional analysis among 67,385 adults with hypertension in Canada
Multimorbidity and blood pressure control: a cross-sectional analysis among 67,385 adults with hypertension in Canada
AbstractBackgroundThere has been conflicting evidence on the association between multimorbidity and blood pressure (BP) control. This study aimed to investigate this associations i...
Association Between Multimorbidity and Root Caries Among Older American Adults
Association Between Multimorbidity and Root Caries Among Older American Adults
Objectives: The objective of this study was to examine the relationship between multimorbidity and root caries among older American adults. Methods: Data from the National Health a...
Chronic Disease Multimorbidity Among the Canadian Population: Prevalence and Associated Lifestyle Factors
Chronic Disease Multimorbidity Among the Canadian Population: Prevalence and Associated Lifestyle Factors
Abstract Background and Rationale With the increasing prevalence of most chronic diseases, multimorbidity is becoming an important public health concern in the Canadian pop...
Abnormal immunity of non-survivors with COVID-19: predictors for mortality
Abnormal immunity of non-survivors with COVID-19: predictors for mortality
Abstract Background The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread all over the world. The specific information about immunity of non-survivors with...
A bibliometric analysis of multimorbidity from 2005 to 2019
A bibliometric analysis of multimorbidity from 2005 to 2019
Context: Multimorbidity is frequently seen in primary care. We aimed to identify and analyze publications on multimorbidity, including those that most influenced this field. Method...
Sarcopenia and preserved bone mineral density in paediatric survivors of high‐risk neuroblastoma with growth failure
Sarcopenia and preserved bone mineral density in paediatric survivors of high‐risk neuroblastoma with growth failure
AbstractBackgroundSurvival from paediatric high‐risk neuroblastoma (HR‐NBL) has increased, but cis‐retinoic acid (cis‐RA), the cornerstone of HR‐NBL therapy, can cause osteoporosis...
Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study
Multimorbidity, polypharmacy and primary prevention in community-dwelling adults in Quebec: a cross-sectional study
AbstractBackgroundPolypharmacy carries the risk of adverse events, especially in people with multimorbidity.ObjectiveTo investigate the prevalence of polypharmacy in community-dwel...

Back to Top